Telomeres and Aging: What Telomere Length Can and Cannot Tell You

What telomeres are

Telomeres are the protective caps at the ends of chromosomes, the long DNA molecules that carry our genes. Elizabeth Blackburn, Carol Greider and Jack Szostak shared the 2009 Nobel Prize in Physiology or Medicine for showing how telomeres protect chromosomes and how an enzyme, telomerase, builds them. [1] Each time a cell copies its DNA, telomeres get slightly shorter. Telomerase counteracts this loss in germ cells and stem cells, but most body cells have little of it, so their telomeres shorten over time. [2] Critically short telomeres trigger a lasting stop in cell division called cellular senescence, which is one hallmark of cellular aging. [2] See cellular senescence explained.

This page is education only. It does not interpret anyone's test result and gives no advice to take a supplement. Aging is not an approved medical indication for any treatment mentioned.

Rare diseases show telomeres matter

In rare inherited conditions called telomere biology disorders, or short-telomere syndromes, defects in the genes that maintain telomeres cause abnormally short or dysfunctional telomeres and a group of premature-aging diseases. [3] Label: established. This is a medical diagnosis made by specialists. It does not mean that a slightly shorter telomere in a healthy adult signals disease.

What large studies find about telomere length and health

Most studies measure telomere length in white blood cells.

• Death from any cause: a meta-analysis of 25 studies (121,749 people, 21,763 deaths) found that each standard-deviation drop in telomere length went with a hazard ratio of 1.09 for death, and the shortest quarter had 26% higher risk than the longest. Results varied between studies, were smaller in people over 80, and depended on the measurement method. [4]
• Two large cohorts: among 12,199 adults aged 43 to 75, the shortest fifth had a 23% higher age-adjusted risk of all-cause death. For cardiovascular and cancer death the ranges were compatible with no difference. [5]
• Heart disease: a meta-analysis of 24 studies found that people in the shortest third of telomere length had a higher relative risk of coronary heart disease (1.54), with moderate variation between studies. [6]
• A caution from genetics: a Mendelian randomization study used inherited gene variants to test cause and effect. Genetically longer telomeres were generally associated with higher risk of several site-specific cancers, and with lower risk of coronary heart disease. [7] This suggests that "longer is better" is too simple.

Label: mixed for telomere length as a predictor, and observational association is not causation. Averages across thousands of people do not tell any one person their own future.

Can a telomere test tell you your biological age?

It helps to separate three questions. Analytical validity asks whether the test measures what it claims, reproducibly. Clinical validity asks whether the result is linked to an outcome. Clinical utility asks whether acting on the result improves health.

• Analytical validity: a review of 25 studies comparing PCR-based methods found the reporting quality low, widely varying agreement between methods and mostly small samples. [8] Another review describes several methods, each with strengths and weaknesses, and says choice depends on the question and the accuracy needed. [9]
• Clinical validity: modest and inconsistent in the studies above. [4]
• Clinical utility: Proper evidence not found. We searched PubMed for trials or reviews showing that testing telomere length in healthy people improves health outcomes and found none (searches on clinical utility and consumer testing returned nothing relevant). Product claims that a telomere result shows your "true age" are marketing claims.

For test detail see telomere length tests: validity and limits and biological age clocks compared. Telomere length is a biomarker, not a health outcome.

Supplements and "telomerase activators"

A telomerase-activating supplement derived from Astragalus has been tested in randomized trials.

• A 1-year trial of 117 relatively healthy adults aged 53 to 87 found that telomere length rose in the lower-amount group compared with a loss in the placebo group; the higher-amount group showed a trend that was not statistically significant. Several authors were employed by or consulted for the sponsor. [10]
• A 6-month trial of 40 healthy adults found longer median telomere length with a different Astragalus-based supplement than placebo. [11]
• A 2025 meta-analysis of 8 randomized trials (750 people) found moderate telomere lengthening, but no improvement in frailty or inflammation measures, larger effects in industry-funded trials, and left long-term cancer potential unaddressed. [12]

Label: promising but limited for lengthening a blood-cell measurement; insufficient evidence that this improves health. Because telomerase is switched on in many cancers, and genetically longer telomeres were associated with higher risk of some cancers, long-term safety is an open question. [1][7]

What can be said in plain terms

Telomeres are real, important cell biology. Short telomere length is associated with higher risk in some large groups. No source we read shows that lengthening telomeres makes people live longer or healthier. See emerging longevity research on reprogramming, gene and cell therapies for early research directions, including telomerase-based ideas. [2]